OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

11084	Companies
243295	Keywords
171462	Articles
131019	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 08/04/2025 at 08:30, 1 year 1 month ago

Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform
Oxurion completes the acquisition of 72% stake in Axiodis CRO, paving the way for an integrated platform focused on clinical data. Intensifies discussions with strategic targets in France and Europe

Acquisition Europe Intégration Clinical Data Oxurion
PRESS RELEASE

published on 08/04/2025 at 08:30, 1 year 1 month ago

Oxurion rondt overname van Axiodis CRO af en versnelt uitbouw van haar Europese platform voor klinische data
Oxurion schliesst erfolgreich die Übernahme von 72% des Aktienkapitals von Axiodis CRO ab und beschleunigt die Gespräche mit strategischen Partnern zur Schaffung eines integrierten Plattforms für klinische Daten

Übernahme Partnerschaften Oxurion Axiodis CRO Klinische Daten
BRIEF

published on 07/30/2025 at 18:05, 1 year 1 month ago

Oxurion Réceptionne une Notification de Transparence Modifiée

Actions Transparence Atlas Special Opportunities Oxurion Bio-pharmaceutique
BRIEF

published on 07/30/2025 at 18:05, 1 year 1 month ago

Oxurion Receives a Modified Transparency Notification

Actions Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/30/2025 at 18:00, 1 year 1 month ago

Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II LLC regarding shareholding threshold

Transparency Notification Shareholding Belgium Oxurion NV Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/30/2025 at 18:00, 1 year 1 month ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV announces receipt of transparency notification on shareholder ownership crossing under threshold due to selling of voting securities. Press release replaces previous announcement

Transparency Notification Biopharmaceutical Oxurion NV Voting Securities Shareholder Ownership
BRIEF

published on 07/25/2025 at 18:05, 1 year 2 months ago

Oxurion Annonce une Augmentation de Capital via Conversion d'Obligations

Augmentation De Capital Biopharmaceutique Actions Ordinaires Atlas Special Opportunities Oxurion
BRIEF

published on 07/25/2025 at 18:05, 1 year 2 months ago

Oxurion Announces Capital Increase via Bond Conversion

Common Shares Capital Increase Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 07/25/2025 at 18:00, 1 year 2 months ago

Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie
Atlas Special Opportunities, LLC convertit 10 obligations convertibles en Oxurion, augmentant le capital de 250 000 EUR. Oxurion reçoit 11 161 618 nouvelles actions pour 250 000 EUR dans le cadre de l'engagement de 20 millions EUR d'Atlas

Innovation Capital Atlas Special Opportunities Oxurion Convertissement
PRESS RELEASE

published on 07/25/2025 at 18:00, 1 year 2 months ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 10 convertible bonds in Oxurion, resulting in a EUR 250,000 capital increase. Oxurion continues focus on innovative therapeutics for elderly vision preservation

Capital Increase Therapeutics Atlas Special Opportunities Oxurion Vision Preservation

Accesswire

Published on 09/26/2026 at 01:00, 18 hours 34 minutes ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 18 hours 34 minutes ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 21 hours 19 minutes ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 1 day 2 hours ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 1 day 4 hours ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

EQS Group

Published on 09/26/2026 at 15:30, 4 hours 4 minutes ago

QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 4 hours 4 minutes ago

QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 4 hours 19 minutes ago

Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 11 hours 49 minutes ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 19 hours 33 minutes ago

Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia

Les Echos

Published on 09/26/2026 at 07:00, 12 hours 34 minutes ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 1 day 1 hour ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 1 day 1 hour ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 1 day 1 hour ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 1 day 1 hour ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE